Apoptosis caused by cathepsins does not require Bid signaling in an in vivo model of progressive myoclonus epilepsy (EPM1)

Cell Death and Differentiation

Volumn 10, Issue 12, 2003, Pages 1329-1335

  Houseweart, M K ^a   Vilaythong, A ^b   Yin, X M ^c   Turk, B ^d   Noebels, J L ^b   Myers, R M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

Apoptosis; Ataxia; Bid; Cathepsin; Cell death; Cerebellum; Cystatin B; EPM1; Granule cell; Lysosome; Progressive myoclonus epilepsy; Stefin B; Unverricht Lundborg

Indexed keywords

CATHEPSIN; CYSTATIN B; CYTOCHROME C; PROTEIN BCL 2; PROTEIN BID; PROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ATAXIA; CELL DEATH; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; ENZYME INHIBITION; IN VIVO STUDY; MOLECULAR MECHANICS; MOUSE; MYOCLONUS EPILEPSY; NICK END LABELING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AGE FACTORS; ANIMALS; APOPTOSIS; ATAXIA; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BLOTTING, WESTERN; CARRIER PROTEINS; CATHEPSINS; CELL DEATH; CEREBELLUM; CYSTATINS; CYTOCHROMES C; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; GENOTYPE; IN SITU NICK-END LABELING; LYSOSOMES; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MYOCLONIC EPILEPSIES, PROGRESSIVE; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0348038755     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401309     Document Type: Article

References (44)

1. Luo X, Budihardjo I, Zou H, Slaughter C and Wang X (1998) Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-490
2. Li H, Zhu H, Xu CJ and Yuan J (1998) Cleavage of BID by caspase-8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 481-501
3. Nitatori T, Sato N, Kominami E and Uchiyama Y (1996) Participation of cathepsins B, H, and L in perikaryal condensation of CA1 pyramidal neurons undergoing apoptosis after brief ischemia. In Intracellular Protein Catabolism Suzuki and Bond (eds) (New York: Plenum Press), 177-185
4. Monney L, Olivier R, Otter I, Jansen B, Poirier GG and Borner C (1998) Role of an acidic compartment in tumor-necrosis-factor-α production of ceramide, activation of caspase-3 and apoptosis. Eur. J. Biochem. 251: 295-303
5. Guicciardi ME, Deussing J, Miyoshi H, Bronk SF, Svingen PA, Peters C, Kaufmann SH and Gores GJ (2000) Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106: 1127-1137
6. Foghsgaard L, Wissing D, Mauch D, Lademann U, Bastholm L, Boes M, Elling F, Leist M and Jäättelä M (2001) Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153: 999-1009
7. Guicciardi ME, Miyoshi H, Bronk SF and Gores GJ (2001) Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-mediated hepatocyte apoptosis and liver injury: implications for therapeutic applications. Am. J. Pathol. 159: 2045-2054
8. Kingham PJ and Pocock JM (2001) Microglial secreted cathepsin B induces neuronal apoptosis. J. Neurochem. 76: 1475-1484
9. 3 involves up-regulation of the TNF receptor 1 and cathepsin B. Int. J. Cancer 93: 224-231
10. Foghsgaard L, Lademann U, Wissing D, Poulsen B and Jäättelä M (2002) Cathepsin B mediates tumor necrosis factor-induced arachidonic acid release in tumor cells. J. Biol. Chem. 277: 39499-39506
11. Fujimoto K, Yamamoto T, Kitano T and Abe S-I (2002) Promotion of cathepsin L activity in newt spermatagonial apoptosis induced by prolactin. FEBS Lett. 521: 43-46
12. Werneburg NW, Guicciardi ME, Bronk SF and Gores GJ (2002) Tumor necrosis factor-α-associated lysosomal permeabilization is cathepsin B dependent. Am. J. Physiol. Gastrointest. Liver Physiol. 283: G947-G956
13. Yuan XM, Li W, Dalen H, Lotem J, Kama R, Sachs L and Brunk UT (2002) Lysosomal destabilization in p53-induced apoptosis. Proc. Natl. Acad. Sci. USA 99: 6286-6291
14. Madge L, Li J-H, Choi J and Pober JS (2003) Inhibition of PI-3 kinase sensitizes vascular endothelial cells to cytokine-initiated cathepsin-dependent apoptosis. J. Biol. Chem. 278: 21295-21306
15. Yuan XM, Li W, Olsson AG and Brunk UT (1997) The toxicity to macrophages of oxidized low-density lipoprotein is mediated though lysosomal damage. Atherosclerosis 133: 153-161
16. Ishisaka R, Utsumi T, Yabuki M, Kanno T, Inoue M and Utsumi K (1998) Activation of caspase-3 like protease by digitonin-treated lysosomes. FEBS Lett. 433: 233-236
17. Vancompemolle K, Van Herreweghe F, Pynaert G, Van de Craen M, De Vod K, Trotty N, Sterling A, Fiers W, Vandenebeele P and Grooten J (1998) Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett. 438: 150-158
18. Ishisaka R, Kanno T, Akiyama J, Yoshioka T, Utsumi K and Utsumi T (2001) Activation of caspase-3 by lysosomal cysteine proteases and its role in 2,2'-azobis-(2-amidino propane) dihydrochloride (AAPH)- induced apoptosis in HL-60 cells. J. Biochem. 129: 35-41
19. Kågedål K, Zhao M, Svensson I and Brunk UT (2001) Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem. J. 359: 335-343
20. Ishisaka R, Utsumi T, Kanno T, Arita K, Katunuma N, Akiyama J and Utsumi K (1999) Participation of a cathepsin L-type protease in the activation of caspase-3. Cell Struct. & Funct. 24: 465-470
21. Gray J, Haran MM, Schneider K, Vesce S, Ray AM, Owen D, White IR, Cutler P and Davis JB (2001) Evidence that inhibition of cathepsin-B contributes to the neuroprotective properties of caspase inhibitor tyr-val-ala-asp-chloromethyl ketone. J. Biol. Chem. 276: 32750-32755
22. Hishita T, Tada-Oikawa S, Tohyama K, Miura Y, Nishihara T, Tohyama Y, Yoshida Y, Uchiyama T and Kawanishi S (2001) Caspase-3 activation by lysosomal enzymes in cytochrome c-independent apoptosis in myelodysplastic syndrome-derived cell line P39. Cancer Res. 61: 2878-2884
23. Turk B, Stoka V, Rozman-Pungercar J, Cirman T, Droga-Mazovec G, Oresic K and Turk V (2002) Apoptotic; pathways: involvement of lysosomal proteases. Biol. Chem. 383: 1035-1044
24. Williams MS and Henkart PA (1994) Apoptotic cell death induced by intracellular proteolysis. J. Immunol. 153: 4247-4255
25. Gobeil S, Boucher CC, Nadeau D and Poirier GG (2001) Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases. Cell Death and Differ. 8: 588-594
26. Schotte P, Criekinge WV, Van de Craen M, Van Loo G, Desmedt M, Grooten J, Cornelissen M, De Ridder L, Vandekerckhove J, Fiers W, Vandenabeele P and Beyaert R (1998) Cathepsin B-mediated activation of the proinflammatory caspase-11. Biochem. & Biophys. Res. Comm. 251: 379-387
27. Stoka V, Turk B, Schendel SL, Kim TH, Cirman T, Snipas SJ, Ellerby LM, Bredesen D, Freeze H, Abrahamson M, Bromme D, Krajewski S, Reed JC, Yin X-M, Turk V and Salvesen GS (2001) Lysosomal protease pathways to apoptosis: cleavage of Bid, not pro-caspases, is the most likely route. J. Biol. Chem. 276: 3149-3157
28. Reiners JJ, Caruso JA, Mathieu P, Chelladurai B, Yin X-M and Kassel D (2002) Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves Bid cleavage. Cell Death Differ. 9: 934-944
29. Houseweart MK, Pennacchio LA, Villaythong A, Noebels JL, Peters C and Myers RM (2003) Cathepsin B but not Cathepsins L or S contributes to the pathogenesis of Unverricht-Lundborg progressive myoclonus epilepsy (EPM1). J. Neurobiology (In Press)
30. Pennacchio LA, Bouley DM, Higgins KM, Scott IMP, Noebels JL and Myers RM (1998) Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nat. Genet. 20: 251-258
31. Yin X-M, Wang K, Gross A, Zhao Y, Zinkel S, Klocke B, Roth KA and Korsmeyer SJ (1999) Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400: 886-891
32. Rushton R and Steinberg H (1963) Mutual potentiation of amphetamine and amylobarbitone measured by activity in rats. Br. J. Pharmacol. 21: 295-305
33. Chakrabarti A, Ekuta JE and Onaivi ES (1998) Neurobehavioral effects of cannabinoid receptor gene expression in mice, Br. Res. Bull 45: 67-74
34. Gil-Parrado S, Fernandez-Montalvan A, Assfalg-Machleidt I, Popp O, Bestvater F, Holloschi A, Knoch TA, Auerswald EA, Welsh K, Reed JC, Fritz H, Fuentes-Prior P, Spiess E, Salvesen GS and Machleidt W (2002) lonomycin-activated calpain triggers apoptosis. A probable role for Bcl-2 family members. J. Biol. Chem. 277: 27217-27226
35. L though caspase interaction. Proc. Natl. Acad. Sci. 95: 554-559
36. Adams JM and Cory S (2001) Life or death decisions by the Bcl-2 protein family. Tr. Bioschem. Sci. 26: 61-66
37. Pillay CS, Elliott E and Dennison C (2002) Endolysosomal proteolysis and its regulation. Biochem. J. 363: 417-429
38. Suter M, Reme C, Grimm C, Wenzel A, Jaattela M, Esser P, Kociok N, Leist M and Richter C (2000) Age related macular degeneration: the lipofuscin component N-retinyl-Nretinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelia[ cells. J. Biol. Chem. 275: 39625-39630
39. Katunuma N, Matsui A, Le QT, Utsumi K, Salvesen G and Ohashi A (2001) Novel procaspase-3 activating cascade mediated by lysoapoptases and its biological significances in apoptosis. Advan. Enzyme Regul. 41: 237-250
40. Ranger AM, Malynn BA and Korsmeyer SJ (2001) Mouse models of cell death. Nat. Genet. 28: 113-118
41. Varfolorneev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, Rebrikov D, Brodianski VM, Kemper OC, Kollet O, Lapidot T, Soffer D, Sobe T, Avraham KB, Goncharov T, Holtmann H, Lonai P and Wallach D (1998) Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9: 267-276
42. Yeh WC, Pompa JL, McCurrach ME, Shu HB, Elia AJ, Shahinian A, Ng M, Wakeham A, Khoo W, Mitchell K, El-Deiry WS, Lowe SW, Goeddel DV and Mak TW (1998) FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279: 1954-1958
43. Zhang J, Cado D, Chen A, Kabra NH and Winoto A (1998) Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392: 296-300
44. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA and Nagata S (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317